These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28165654)

  • 1. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
    Kakumu T; Sato M; Goto D; Kato T; Yogo N; Hase T; Morise M; Fukui T; Yokoi K; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
    Cancer Sci; 2017 Apr; 108(4):732-743. PubMed ID: 28165654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
    Tanaka I; Sato M; Kato T; Goto D; Kakumu T; Miyazawa A; Yogo N; Hase T; Morise M; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
    Cancer Sci; 2018 Jun; 109(6):1843-1852. PubMed ID: 29624814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis.
    Tang Y; Yan G; Song X; Wu K; Li Z; Yang C; Deng T; Sun Y; Hu X; Yang C; Bai H; Li H; Tan W; Ye M; Liu J
    J Cell Mol Med; 2015 Dec; 19(12):2806-17. PubMed ID: 26354852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1.
    Reeves ME; Baldwin ML; Aragon R; Baldwin S; Chen ST; Li X; Mohan S; Amaar YG
    BMC Res Notes; 2012 May; 5():239. PubMed ID: 22591718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIST1H3D: A promising therapeutic target for lung cancer.
    Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
    Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth.
    Zhang L; Xu B; Qiang Y; Huang H; Wang C; Li D; Qian J
    J Cell Mol Med; 2015 Apr; 19(4):799-805. PubMed ID: 25656529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas.
    Matsuyama Y; Suzuki M; Arima C; Huang QM; Tomida S; Takeuchi T; Sugiyama R; Itoh Y; Yatabe Y; Goto H; Takahashi T
    Mol Carcinog; 2011 Apr; 50(4):301-9. PubMed ID: 21465578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.
    Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer.
    Martens-de Kemp SR; Nagel R; Stigter-van Walsum M; van der Meulen IH; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
    Clin Cancer Res; 2013 Apr; 19(8):1994-2003. PubMed ID: 23444224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells.
    Bakke J; Wright WC; Zamora AE; Oladimeji P; Crawford JC; Brewer CT; Autry RJ; Evans WE; Thomas PG; Chen T
    BMC Cancer; 2019 Mar; 19(1):253. PubMed ID: 30898113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
    Papadodima O; Moulos P; Koryllou A; Piroti G; Kolisis F; Chatziioannou A; Pletsa V
    PLoS One; 2016; 11(7):e0160248. PubMed ID: 27467507
    [No Abstract]   [Full Text] [Related]  

  • 14. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
    Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
    Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer.
    Cron KR; Zhu K; Kushwaha DS; Hsieh G; Merzon D; Rameseder J; Chen CC; D'Andrea AD; Kozono D
    PLoS One; 2013; 8(9):e73710. PubMed ID: 24040035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.
    Bae K; Park KE; Han J; Kim J; Kim K; Yoon KA
    Oncotarget; 2016 Apr; 7(14):18076-84. PubMed ID: 26716515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
    Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.